MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded delivery order SPE2DP26F9923 to DMS Pharmaceutical Group Inc on September 14, 2026, under the base administrative contract SPE2DX25D9900. This award, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of two units of meloxicam tablets, identified by national stock number 6505015413243 and purchase request 7018335497. The total contract price is 90.00 dollars, with each unit priced at 45.00 dollars. The delivery is designated for the USS Tucson and includes specific instructions regarding shipment, FOB destination, and medical substitution requirements. This order operates under a broader base contract established on April 2, 2025, which incorporates standard commercial item clauses.
General Info
Contract Value
$90Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
